Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
mycosis fungoides/adenosina
Il collegamento viene salvato negli appunti
13 risultati
Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Adenosine deaminase activities in sera were measured in 18 psoriatic patients, 8 mycosis fungoides patients, and 9 patients with adult T cell leukemia. Adenosine deaminase activity in the sera of the psoriatic patients showed no significant increase. An elevated adenosine deaminase activity was
Clinical significance of serum adenosine deaminase activity in patients with mycosis fungoides.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Adenosine deaminase is one of the key enzymes in purine nucleotide degradation. This enzyme exists in most of the human tissues and the activity is high in lymphatic tissues, especially in T lymphocytes. Elevated adenosine deaminase activity in T cell leukemia has been reported, and its inhibitor,
Normal serum adenosine deaminase activity in mycosis fungoides.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).
Solo gli utenti registrati possono tradurre articoli
Entra registrati
OBJECTIVE
To review recent studies of systemic therapy for mycosis fungoides and the Sézary syndrome (cutaneous T-cell lymphomas).
METHODS
English-language articles indexed in MEDLINE from 1988 through 1994.
METHODS
All therapeutic studies were selected.
METHODS
The data were abstracted without
[Identification of Langerhans cells in dermatology].
Solo gli utenti registrati possono tradurre articoli
Entra registrati
This paper describes our own findings on the role of Langerhans' cells in dermatology and discusses literature data on their detection in seven different dermatoses. The skin is an integral part of immune system. During the past 30 years, increasing evidence has been accumulated that the skin
Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The cutaneous T-cell lymphomas (CTCL) comprise a heterogeneous group of entities. The WHO classification distinguishes indolent low-risk entities, including mycosis fungoides/Sézary syndrome (MF/SS), from aggressive entities, including peripheral T-cell lymphoma and its variants and HTLV-1
Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Promising results in the treatment of indolent lymphomas have been reported with the use of 2'deoxycoformycin. This antimetabolite, an adenosine deaminase inhibitor, also shows particular efficacy in hairy cell leukemia. Of 65 patients treated to date, 44 have achieved complete and lasting remission
Pentostatin treatment of cutaneous T-cell lymphoma.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Mycosis fungoides is an indolent primary cutaneous T-cell lymphoma (CTCL) that usually progresses from localized skin lesions to systemic disease. Sézary syndrome is a distinct variant characterized by generalized erythroderma and circulating cerebriform cells in the peripheral blood. The malignant
Clinical pharmacology of deoxycoformycin.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Deoxycoformycin (DCF) is an inhibitor of adenosine deaminase (ADA). Twenty-one courses of DCF were administered to 13 patients ranging in age from 15 to 78 yr. Eight patients had T-cell disorders, and five patients had non-T-cell malignancies. The i.v. bolus dose was escalated from 5 to 30 mg/sq
2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
A new antimetabolite, 2'-deoxycoformycin (pentostatin), has striking antitumor activity in several lymphoid neoplasms. Isolated from cultured soil organisms, this purine analogue is a potent inhibitor of adenosine deaminase (ADA), and is thus selectively toxic to lymphocytes. Early clinical trials
Efficacy of methotrexate as anti-inflammatory and anti-proliferative drug in dermatology: Three case reports.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Methotrexate (MTX) is a folic acid analog with anti-proliferative (anti-neoplastic, cytotoxic), immunosuppressive and anti-inflammatory properties, which has been used in the treatment of various cutaneous disorders, such as psoriasis, keratoacanthoma, pityriasis rubra pilaris, atopic dermatitis,
Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Fludarabine phosphate is the 2-fluoro, 5'-monophosphate derivative of vidarabine (ara-A) with the advantages of resistance to deamination by adenosine deaminase (ADA) and improved solubility. The mechanism of cytotoxic action of the compound appears to involve metabolic conversion to the active
An investigation of 2'-deoxycoformycin in the treatment of cutaneous T-cell lymphoma.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
We have investigated the use of 2'-deoxycoformycin (DCF), a potent inhibitor of adenosine deaminase (ADA), in the treatment of 4 patients with advanced mycosis fungoides (MF). Since DCF has demonstrated an adverse effect in vitro and in vivo on the survival of leukemia T-cell lines, it appeared
Il database di erbe medicinali più completo supportato dalla scienza
- Funziona in 55 lingue
- Cure a base di erbe sostenute dalla scienza
- Riconoscimento delle erbe per immagine
- Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
- Leggi le pubblicazioni scientifiche relative alla tua ricerca
- Cerca le erbe medicinali in base ai loro effetti
- Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate
